Comparative Effectiveness of Sitagliptin Compared to Sulphonylureas for Type 2 Diabetes Among Elderly Patients Inadequately Controlled on Metformin

被引：0
|
作者：
Sharma, Manuj [1 ]
Nazareth, Irwin [1 ]
Petersen, Irene [1 ,2 ]
机构：
[1] UCL, London, England
[2] Aarhus Univ Hosp, Aarhus, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
730
引用
收藏
页码：440 / 440
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
    Gao, Yan
    Yoon, Kun Ho
    Chuang, Lee-Ming
    Mohan, Viswanathan
    Ning, Guang
    Shah, Sanjiv
    Jang, Hak Chul
    Wu, Ta-Jen
    Johns, Don
    Northrup, Justin
    Brodows, Robert
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 69 - 76
  • [42] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
    Bailey, C. J.
    Gross, J. L.
    Bastone, L.
    Bastien, A.
    List, J. F.
    DIABETOLOGIA, 2009, 52 : S76 - S76
  • [43] Persistence of initial treatment with metformin and/or sulphonylureas in patients with type 2 diabetes
    Jermendy, G.
    Wittmann, I.
    Nagy, L.
    Kiss, Z.
    Rokszin, G.
    Abonyi-Toth, Z.
    Katona, L.
    Paragh, G.
    Karadi, I.
    Merkely, B.
    DIABETOLOGIA, 2011, 54 : S382 - S382
  • [44] Comparative Safety and Effectiveness of Sitagliptin in Patients With Type 2 Diabetes and Heart Failure
    Weir, Daniala L.
    Senthilselvan, A.
    Dyck, Jason R.
    Sandhu-Minhas, Jasjeet K.
    Mcalister, Finlay A.
    Eurich, Dean T.
    DIABETES, 2013, 62 : A372 - A372
  • [45] The Comparative Safety and Effectiveness of Sitagliptin in Patients with Type 2 Diabetes and Heart Failure
    Weir, Daniala L.
    McAlister, Finlay A.
    Senthilselvan, Sentil
    Dyck, Jason R.
    Sandhu-Minhas, Jasjeet K.
    Eurich, Dean T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 131 - 131
  • [46] Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
    Klarenbach, Scott
    Cameron, Chris
    Singh, Sumeet
    Ur, Ehud
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (16) : E1213 - E1220
  • [47] COST-EFFECTIVENESS OF SITAGLIPTIN COMPARED TO SULPHONYLUREA AS AN ADD-ON TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN GREECE
    Athanasakis, K.
    Zhuo, J.
    Chen, J.
    Boubouchairopoulou, N.
    Tarantilis, F.
    Papageorgiou, M.
    Retsa, P.
    Brandtmuller, A.
    Tunceli, K.
    Karokis, A.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2015, 18 (07) : A608 - A608
  • [48] Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
    Scheen, Andre J.
    Charpentier, Guillaume
    Ostgren, Carl Johan
    Hellqvist, Asa
    Gause-Nilsson, Ingrid
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (07) : 540 - 549
  • [49] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
    Hermansen, K.
    Kipnes, M.
    Luo, E.
    Fanurik, D.
    Khatami, H.
    Stein, P.
    DIABETES OBESITY & METABOLISM, 2007, 9 (05): : 733 - 745
  • [50] Safety and efficacy of ertugliflozin after 52 weeks in patients with type 2 diabetes inadequately controlled on metformin and sitagliptin: VERTIS SITA2 trial extension
    Eldor, R.
    Liu, J.
    Dagogo-Jack, S.
    Amorin, G.
    Johnson, J.
    Liao, Y.
    Huyck, S.
    Golm, G.
    Terra, S. G.
    Mancuso, J. P.
    Engel, S. S.
    Lauring, B.
    DIABETOLOGIA, 2017, 60 : S21 - S21
12345